Teva, Sandoz Launch At-Risk Versions of Pfizer Drug
The U.S. Food and Drug Administration has given the green light to three generic drug makers' plans to market their own versions of Pfizer's Zithromax antibiotic. Two of the companies have...To view the full article, register now.
Already a subscriber? Click here to view full article